Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHSE:600196) announces a share repurchase program. Under the program, the company will repurchase up to CNY 200 million worth of its common stock. The shares will repurchased at a price of CNY 30 per share.

The program will be sourced from company's own funds. The purpose of the program is ESOP or equity incentives. The program will be valid for 6 months i.e September 25, 2024.